Antagonistic effects of RAC1 and tumor-related RAC1b on NIS expression in thyroid

in Journal of Molecular Endocrinology
Authors:
Márcia Faria Serviço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de Lisboa Norte-Hospital Santa Maria, Lisboa, Portugal
BioISI – Biosystems and Integrative Sciences Institute, Faculdade de Ciências da Universidade de Lisboa, Lisboa, Portugal
Departamento de Genética Humana, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal

Search for other papers by Márcia Faria in
Current site
Google Scholar
PubMed Close
,
Daniela Félix Serviço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de Lisboa Norte-Hospital Santa Maria, Lisboa, Portugal
ISAMB – Instituto de Saúde Ambiental, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal

Search for other papers by Daniela Félix in
Current site
Google Scholar
PubMed Close
,
Rita Domingues Serviço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de Lisboa Norte-Hospital Santa Maria, Lisboa, Portugal
ISAMB – Instituto de Saúde Ambiental, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal

Search for other papers by Rita Domingues in
Current site
Google Scholar
PubMed Close
,
Maria João Bugalho Serviço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de Lisboa Norte-Hospital Santa Maria, Lisboa, Portugal
Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal

Search for other papers by Maria João Bugalho in
Current site
Google Scholar
PubMed Close
,
Paulo Matos BioISI – Biosystems and Integrative Sciences Institute, Faculdade de Ciências da Universidade de Lisboa, Lisboa, Portugal
Departamento de Genética Humana, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal

Search for other papers by Paulo Matos in
Current site
Google Scholar
PubMed Close
, and
Ana Luísa Silva Serviço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de Lisboa Norte-Hospital Santa Maria, Lisboa, Portugal
ISAMB – Instituto de Saúde Ambiental, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal

Search for other papers by Ana Luísa Silva in
Current site
Google Scholar
PubMed Close

Correspondence should be addressed to A L Silva: silva.r.analuisa@gmail.com
DOI:
https://doi.org/10.1530/JME-19-0195
Volume/Issue:
Volume 63: Issue 4
Article Type:
Research Article
Page Range:
309–320
Online Publication Date:
Nov 2019
Copyright:
© 2019 Society for Endocrinology 2019
Restricted access
Rent on DeepDyve

Sign up for journal news

Thyroid cancer (TC) is the most common endocrine malignancy. The sodium–iodide symporter (NIS), responsible for active transport of iodide into thyroid cells, allows the use of radioactive iodine (RAI) as the systemic treatment of choice for TC metastatic disease. Still, patients with advanced forms of TC often lose the ability to respond to RAI therapy, which results in worse survival rates. We have shown that the overexpression of RAC1b, a tumor-related RAC1 splice variant, is associated with less favorable clinical outcomes in differentiated TCs derived from the follicular epithelial (DTCs). RAC1b overexpression is also significantly associated with the presence of MAPK-activating BRAFV600E mutation, which has been previously implicated in the loss of NIS expression. Here, we show that increased RAC1b levels are associated with NIS downregulation in DTCs and demonstrate that ectopic overexpression of RAC1b in non-transformed thyroid cells is sufficient to decrease TSH-induced NIS expression, antagonizing the positive effect of the canonically spliced RAC1 GTPase. Moreover, we clearly document for the first time in thyroid cells that both NIS expression and iodide uptake are hampered by RAC1 inhibition, highlighting the role of RAC1 in promoting TSH-induced NIS expression. Our findings support a role for RAC1 and RAC1b signaling in the regulation of NIS expression in thyroid cells and suggest that RAC1b in cooperation with other cancer-associated signaling cues may be implicated in the response of DTCs to RAI therapy.

Supplementary Materials

    • Figure 1 supplemental: NIS and RAC1b expression data retrieved from TCGA database. NIS and RAC1b isoform expression data was collected from The Cancer Genome Atlas (TCGA) project [Thyroid Carcinoma (THCA) project] using the TSVdb tool (Sun et al. 2018). NIS and RAC1b RNA-Seq data was retrieved in the RSEM format (Li & Dewey 2011). Results are depicted as Tukey’s boxplots of the LOG2 RSEM values of each sample, comparing primary PTC (n=501) and normal solid thyroid tissue (n=59) data sets. The existence of significant differences between the two datasets was evaluated using a two-tailed Mann-Whitney’s u-test, assuming a significance level of α=0.05.

Journal of Molecular Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.

The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.

More information is on the Reasons to publish page.

Sept 2018 onwards Past Year Past 30 Days
Full Text Views 497 34 0
PDF Downloads 295 10 0

 

  • Collapse
  • Expand
Online ISSN:
1479-6813
Print ISSN:
0952-5041
Copyright:
© 2019 Society for Endocrinology 2019
Page(s):
12
Article Type:
Research Article
Received Date:
08 Sep 2019
Accepted Date:
07 Oct 2019
Print Publication Date:
01 Nov 2019
Online Publication Date:
Nov 2019
Keywords:
thyroid cancer; sodium-iodide symporter; Rho GTPases; signaling